biotech
James D. Watson Helix Award for Biotechnology Industry Leadership
Filed in archive Corporate and Industrial News , Meetings and Other Events by ruth on February 19, 2006
During the recently concluded 8th Annual BIO CEO & Investor Conference at the Waldorf-Astoria, the Biotechnology

BlogPicture

Industry Organization (BIO) announced this year's winners of the James D. Watson Helix Award for Biotechnology Industry Leadership.

Large Capitalization: Genentech Inc., of South San Francisco, Calif.
Emerging Company/Mid-Capitalization: Alnylam Pharmaceuticals Inc., of Cambridge, Mass.
International: Novo Nordisk Inc., of Princeton, N.J.
"These companies have been selected and recognized as industry leaders by being nominated by their peers. Each firm is devoting its resources to developing cutting-edge science that will lead to breakthrough, life saving therapies. I congratulate them for their success and commitment to saving and improving patient lives," said Jim Greenwood, BIO's president and CEO.


Read more about the award from BIO. You may want to view webcasts of the companies which participated at the conference here.

Permalink: James D. Watson Helix Award for Biotechnology Industry Leadership
Tags: biotech  investor  biotechnology  industry  award  biotechnology+industry  james+watson  award+biotechnolog 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/15693
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for James D. Watson Helix Award for Biotechnology Industry Leadership:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 3 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!